Aims: Tumor microenvironment is a strong determinant for the acquisition of metastatic potential of cancer cells. We have recently demonstrated that cancer-associated fibroblasts (CAFs) elicit a redox-dependent epithelial-mesenchymal transition (EMT) in prostate cancer (PCa) cells, driven by cycloxygenase-2/hypoxia-inducible factor-1 (HIF-1)/nuclear factor-κB pathway and enhancing tumor aggressiveness. Here, we investigated the involvement of microRNAs (miRNAs) in tumor-stroma interplay to identify possible tools to counteract oxidative stress and metastasis dissemination. Results: We found that miR-205 is the most downmodulated miRNA in PCa cells upon CAF stimulation, due to direct transcriptional repression by HIF-1, a known redox-sensitive transcription factor. Rescue experiments demonstrated that ectopic miR-205 overexpression in PCa cells counteracts CAF-induced EMT, thus impairing enhancement of cell invasion, acquisition of stem cell traits, tumorigenicity, and metastatic dissemination. In addition, miR-205 blocks tumor-driven activation of surrounding fibroblasts by reducing pro-inflammatory cytokine secretion. Innovation: Overall, such findings suggest miR-205 as a brake against PCa metastasis by blocking both the afferent and efferent arms of the circuit between tumor cells and associated fibroblasts, thus interrupting the pro-oxidant and pro-inflammatory circuitries engaged by reactive stroma. Conclusion: The evidence that miR-205 replacement in PCa cells is able not only to prevent but also to revert the oxidative/pro-inflammatory axis leading to EMT induced by CAFs sets the rationale for developing miRNA-based approaches to prevent and treat metastatic disease. Antioxid. Redox Signal. 20, 1045–1059.
Get full access to this article
View all access options for this article.
References
1.
AprelikovaO, YuX, PallaJ, WeiBR, JohnS, YiM, StephensR, SimpsonRM, RisingerJI, JazaeriA, and NiederhuberJ. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle, 9: 4387–4398, 2010.
BhatnagarN, LiX, PadiSK, ZhangQ, TangMS, and GuoB. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis, 1: e105, 2010.
4.
BhowmickNA, ChytilA, PliethD, GorskaAE, DumontN, ShappellS, WashingtonMK, NeilsonEG, and MosesHL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 303: 848–851, 2004.
5.
BhowmickNA, NeilsonEG, and MosesHL. Stromal fibroblasts in cancer initiation and progression. Nature, 432: 332–337, 2004.
6.
CalvaniM, ComitoG, GiannoniE, and ChiarugiP. Time-dependent stabilization of hypoxia inducible factor-1alpha by different intracellular sources of reactive oxygen species. PLoS One, 7: e38388, 2012.
7.
CannitoS, NovoE, di BonzoLV, BuslettaC, ColombattoS, and ParolaM. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal, 12: 1383–1430, 2010.
8.
CastellonEA, ValenzuelaR, LilloJ, CastilloV, ContrerasHR, GallegosI, MercadoA, and HuidobroC. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis. Biol Res, 45: 297–305, 2012.
9.
ChenKF, LaiYY, SunHS, and TsaiSJ. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha. Nucleic Acids Res, 33: 5190–5198, 2005.
10.
ChiavarinaB, Whitaker-MenezesD, MignecoG, Martinez-OutschoornUE, PavlidesS, HowellA, TanowitzHB, CasimiroMC, WangC, PestellRG, GrieshaberP, CaroJ, SotgiaF, and LisantiMP. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: autophagy drives compartment-specific oncogenesis. Cell Cycle, 9: 3534–3551, 2010.
11.
CirriP, and ChiarugiP. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res, 1: 482–497, 2011.
12.
CirriP, and ChiarugiP. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev, 31: 195–208, 2012.
13.
ComitoG, GiannoniE, DiGP, SeguraCP, GerliniG, and ChiarugiP. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett, 324: 31–41, 2012.
14.
DeWO, and MareelM. Role of tissue stroma in cancer cell invasion. J Pathol, 200: 429–447, 2003.
15.
DudaDG, DuyvermanAM, KohnoM, SnuderlM, StellerEJ, FukumuraD, and JainRK. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A, 107: 21677–21682, 2010.
16.
EltzschigHK, AbdullaP, HoffmanE, HamiltonKE, DanielsD, SchonfeldC, LofflerM, ReyesG, DuszenkoM, KarhausenJ, RobinsonA, WestermanKA, CoeIR, and ColganSP. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med, 202: 1493–1505, 2005.
17.
FeigeE, YokoyamaS, LevyC, KhaledM, IgrasV, LinRJ, LeeS, WidlundHR, GranterSR, KungAL, and FisherDE. Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci U S A, 108: E924–E933, 2011.
18.
FiaschiT, GiannoniE, TaddeiML, CirriP, MariniA, PintusG, NativiC, RichichiB, ScozzafavaA, CartaF, TorreE, SupuranCT, and ChiarugiP. Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle, 12: 1791–1801, 2013.
19.
GandelliniP, FoliniM, LongoniN, PennatiM, BindaM, ColecchiaM, SalvioniR, SupinoR, MorettiR, LimontaP, ValdagniR, DaidoneMG, and ZaffaroniN. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res, 69: 2287–2295, 2009.
20.
GandelliniP, FoliniM, and ZaffaroniN. Towards the definition of prostate cancer-related microRNAs: where are we now?. Trends Mol Med, 15: 381–390, 2009.
21.
GandelliniP, ProfumoV, CasamicheleA, FendericoN, BorrelliS, PetrovichG, SantilliG, CallariM, ColecchiaM, PozziS, DeCM, FoliniM, ValdagniR, MantovaniR, and ZaffaroniN. miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ, 19: 1750–1760, 2012.
22.
GiannoniE, BianchiniF, CaloriniL, and ChiarugiP. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal, 14: 2361–2371, 2011.
23.
GiannoniE, BianchiniF, MasieriL, SerniS, TorreE, CaloriniL, and ChiarugiP. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res, 70: 6945–6956, 2010.
24.
GiannoniE, ParriM, and ChiarugiP. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal, 16: 1248–1263, 2012.
25.
GregoryPA, BertAG, PatersonEL, BarrySC, TsykinA, FarshidG, VadasMA, Khew-GoodallY, and GoodallGJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10: 593–601, 2008.
26.
HanahanD, and WeinbergRA. Hallmarks of cancer: the next generation. Cell, 144: 646–674, 2011.
27.
HinzB, PhanSH, ThannickalVJ, PrunottoM, DesmouliereA, VargaJ, DeWO, MareelM, and GabbianiG. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol, 180: 1340–1355, 2012.
28.
HungCS, LiuHH, LiuJJ, YehCT, ChangTC, WuCH, HoYS, WeiPL, and ChangYJ. MicroRNA-200a and −200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Ann Surg Oncol, 2012.
29.
KalluriR, and ZeisbergM. Fibroblasts in cancer. Nat Rev Cancer, 6: 392–401, 2006.
30.
KangJW, ParkYS, LeeDH, KimJH, KimMS, BakY, HongJ, and YoonDY. Intracellular interaction of interleukin (IL)-32alpha with protein kinase Cepsilon (PKCepsilon) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells. J Biol Chem, 287: 35556–35564, 2012.
31.
KlarmannGJ, HurtEM, MathewsLA, ZhangX, DuhagonMA, MistreeT, ThomasSB, and FarrarWL. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis, 26: 433–446, 2009.
32.
KorpalM, EllBJ, BuffaFM, IbrahimT, BlancoMA, Celia-TerrassaT, MercataliL, KhanZ, GoodarziH, HuaY, WeiY, HuG, GarciaBA, RagoussisJ, AmadoriD, HarrisAL, and KangY. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med, 17: 1101–1108, 2011.
33.
ManaloDJ, RowanA, LavoieT, NatarajanL, KellyBD, YeSQ, GarciaJG, and SemenzaGL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 105: 659–669, 2005.
34.
ManiSA, GuoW, LiaoMJ, EatonEN, AyyananA, ZhouAY, BrooksM, ReinhardF, ZhangCC, ShipitsinM, CampbellLL, PolyakK, BriskenC, YangJ, and WeinbergRA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133: 704–715, 2008.
35.
Martinez-OutschoornUE, TrimmerC, LinZ, Whitaker-MenezesD, ChiavarinaB, ZhouJ, WangC, PavlidesS, Martinez-CantarinMP, CapozzaF, WitkiewiczAK, FlomenbergN, HowellA, PestellRG, CaroJ, LisantiMP, and SotgiaF. Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle, 9: 3515–3533, 2010.
36.
MateescuB, BatistaL, CardonM, GruossoT, deFY, MarianiO, NicolasA, MeynielJP, CottuP, Sastre-GarauX, and Mechta-GrigoriouF. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med, 17: 1627–1635, 2011.
37.
MizuguchiY, SpechtS, LunzJGIII, IsseK, CorbittN, TakizawaT, and DemetrisAJ. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. PLoS One, 7: e32449, 2012.
38.
Morote-GarciaJC, RosenbergerP, NivillacNM, CoeIR, and EltzschigHK. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology, 136: 607–618, 2009.
39.
MouilletJF, ChuT, NelsonDM, MishimaT, and SadovskyY. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J, 24: 2030–2039, 2010.
40.
MurphyMP. Modulating mitochondrial intracellular location as a redox signal. Sci Signal, 5: e39, 2012.
41.
MusumeciM, CoppolaV, AddarioA, PatriziiM, Maugeri-SaccaM, MemeoL, ColarossiC, FrancescangeliF, BiffoniM, ColluraD, GiacobbeA, D'UrsoL, FalchiM, VenneriMA, MutoG, DeMR, and BonciD. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene, 30: 4231–4242, 2011.
42.
NagrathS, SequistLV, MaheswaranS, BellDW, IrimiaD, UlkusL, SmithMR, KwakEL, DigumarthyS, MuzikanskyA, RyanP, BalisUJ, TompkinsRG, HaberDA, and TonerM. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 450: 1235–1239, 2007.
43.
NarravulaS, and ColganSP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol, 166: 7543–7548, 2001.
44.
NietoMA, and CanoA. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol, 22: 361–368, 2012.
45.
OrlottiNI, Cimino-RealeG, BorghiniE, PennatiM, SissiC, PerroneF, PalumboM, DaidoneMG, FoliniM, and ZaffaroniN. Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage. Autophagy, 8: 1185–1196, 2012.
46.
ParriM, and ChiarugiP. Redox molecular machines involved in tumor progression. Antioxid Redox Signal, 19: 1828–1845, 2013.
47.
PavlidesS, TsirigosA, VeraI, FlomenbergN, FrankPG, CasimiroMC, WangC, FortinaP, AddyaS, PestellRG, Martinez-OutschoornUE, SotgiaF, and LisantiMP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: a transcriptional informatics analysis with validation. Cell Cycle, 9: 2201–2219, 2010.
48.
PellacaniD, OldridgeEE, CollinsAT, and MaitlandNJ. Prominin-1 (CD133) expression in the prostate and prostate cancer: a marker for quiescent stem cells. Adv Exp Med Biol, 777: 167–184, 2013.
49.
PiovanC, PalmieriD, DiLG, BraccioliL, CasaliniP, NuovoG, TortoretoM, SassoM, PlantamuraI, TriulziT, TaccioliC, TagliabueE, IorioMV, and CroceCM. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol, 6: 458–472, 2012.
50.
RadiskyDC, LevyDD, LittlepageLE, LiuH, NelsonCM, FataJE, LeakeD, GoddenEL, AlbertsonDG, NietoMA, WerbZ, and BissellMJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436: 123–127, 2005.
TrimmerC, SotgiaF, Whitaker-MenezesD, BallietRM, EatonG, Martinez-OutschoornUE, PavlidesS, HowellA, IozzoRV, PestellRG, SchererPE, CapozzaF, and LisantiMP. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther, 11: 383–394, 2011.
56.
TryndyakVP, BelandFA, and PogribnyIP. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer, 126: 2575–2583, 2010.
57.
TucciP, AgostiniM, GrespiF, MarkertEK, TerrinoniA, VousdenKH, MullerPA, DotschV, KehrloesserS, SayanBS, GiacconeG, LoweSW, TakahashiN, VandenabeeleP, KnightRA, LevineAJ, and MelinoG. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci U S A, 109: 15312–15317, 2012.
58.
ZhengW, KuhlickeJ, JackelK, EltzschigHK, SinghA, SjoblomM, RiedererB, WeinholdC, SeidlerU, ColganSP, and KarhausenJ. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J, 23: 204–213, 2009.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
